|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-4-6
|
|
pubmed:abstractText |
Differences in subtypes, hepatitis B early antigen (HBeAg)-negative variants, and drug resistance mutations all seem to influence the clinical and therapeutic outcome in patients with chronic hepatitis B virus (HBV) infection. Information available on the prevalence and distribution of distinct HBV variants in HIV-positive patients is scarce.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1525-4135
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
557-61
|
|
pubmed:meshHeading |
pubmed-meshheading:17224847-Adult,
pubmed-meshheading:17224847-Anti-HIV Agents,
pubmed-meshheading:17224847-Drug Resistance, Viral,
pubmed-meshheading:17224847-Female,
pubmed-meshheading:17224847-Genes, Viral,
pubmed-meshheading:17224847-Genotype,
pubmed-meshheading:17224847-HIV Infections,
pubmed-meshheading:17224847-Hepatitis B, Chronic,
pubmed-meshheading:17224847-Hepatitis B virus,
pubmed-meshheading:17224847-Humans,
pubmed-meshheading:17224847-Lamivudine,
pubmed-meshheading:17224847-Male,
pubmed-meshheading:17224847-Middle Aged,
pubmed-meshheading:17224847-Mutation
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.
|
|
pubmed:affiliation |
Service of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
